CAMPBELLVILLE, ON, Feb. 2 /CNW/ - NIR Diagnostics Inc. (TSX Venture: NID), a leading-edge developer of near-infrared diagnostic instruments, today announced the issuance of United States patent No. 6,841,132, entitled “Sample Tab”, a patent under license by the company. The “Sample Tab” patent provides protection for the patient sample interface of the HemoNIR(TM) device. HemoNIR(TM) is a portable, reagentless co-oximetry device that uses a droplet of whole blood to monitor non functional hemoglobin.
